Trial Outcomes & Findings for Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease (NCT NCT02850159)

NCT ID: NCT02850159

Last Updated: 2024-05-07

Results Overview

Change of a self-assessment scale for evaluating participant freezing of gait (FOG) symptoms after non-invasive brain stimulation (NIBS) for 5 consecutive days ((freezing of gait questionnaire (FOG-Q) after NIBS) - (FOG-Q before NIBS) Minimum score: -5 Maximum score: 0 Lower values represent a better outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

32 participants

Primary outcome timeframe

Assessed at T0, pre-NIBS at day 1 and T1, immediately after NIBS at day 5

Results posted on

2024-05-07

Participant Flow

Participant milestones

Participant milestones
Measure
Dual-mode Group
the dual-mode NIBS with high-frequency rTMS and tDCS simultaneously rTMS and tDCS: Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously
rTMS Group
high-frequency rTMS and sham tDCS rTMS: Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and sham anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously
Overall Study
STARTED
16
16
Overall Study
COMPLETED
16
16
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dual-mode Group
n=16 Participants
the dual-mode NIBS with high-frequency rTMS and tDCS simultaneously rTMS and tDCS: Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously
rTMS Group
n=16 Participants
high-frequency rTMS and sham tDCS rTMS: Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and sham anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously
Total
n=32 Participants
Total of all reporting groups
Age, Continuous
63.6 years
STANDARD_DEVIATION 7.5 • n=5 Participants
63.8 years
STANDARD_DEVIATION 8.3 • n=7 Participants
63.7 years
STANDARD_DEVIATION 7.8 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
5 Participants
n=7 Participants
12 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants
11 Participants
n=7 Participants
20 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
16 Participants
n=5 Participants
16 Participants
n=7 Participants
32 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
Korea, Republic of
16 participants
n=5 Participants
16 participants
n=7 Participants
32 participants
n=5 Participants
Right Handedness
16 Participants
n=5 Participants
16 Participants
n=7 Participants
32 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Assessed at T0, pre-NIBS at day 1 and T1, immediately after NIBS at day 5

Change of a self-assessment scale for evaluating participant freezing of gait (FOG) symptoms after non-invasive brain stimulation (NIBS) for 5 consecutive days ((freezing of gait questionnaire (FOG-Q) after NIBS) - (FOG-Q before NIBS) Minimum score: -5 Maximum score: 0 Lower values represent a better outcome.

Outcome measures

Outcome measures
Measure
Dual-mode Group
n=16 Participants
the dual-mode NIBS with high-frequency rTMS and tDCS simultaneously rTMS and tDCS: Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously
rTMS Group
n=16 Participants
high-frequency rTMS and sham tDCS rTMS: Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and sham anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously
Change of Freezing of Gait Questionnaire (FOG-Q)
12.0 score
Standard Deviation 5.0
13.9 score
Standard Deviation 4.9

Adverse Events

Dual-mode Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

rTMS Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Won Hyuk Chang

Samsung Medical Center

Phone: 82234102818

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place